Medication adherence patterns in adult renal transplant recipients.

Patient adherence to immunosuppressive medications adherence is crucial to survival of the patient and a transplanted kidney, yet adherence is variable. Using a prospective, descriptive design, immunosuppressive medication adherence of 44 renal transplant recipients was followed for 6 months at a Midwestern transplant center using electronic monitoring. Four medication adherence patterns emerged from a hierarchical cluster analysis: those who took medications on time, those who took medications on time with late/missed doses, those who rarely took medications on time and who were late with morning and/or evening doses, and those who missed doses. This study is a step toward developing and implementing interventions targeted to specific patterns of poor adherence.

[1]  N. Ambrosino,et al.  Pattern of variables describing desaturator COPD patients, as revealed by cluster analysis. , 2005, Chest.

[2]  F. Dobbels,et al.  Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[3]  A. Israni,et al.  Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. , 2005, Journal of the American Society of Nephrology : JASN.

[4]  John Urquhart,et al.  Patient adherence to prescribed antimicrobial drug dosing regimens. , 2005, Journal of Antimicrobial Chemotherapy.

[5]  P. Roderick,et al.  Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring , 2004, Transplantation.

[6]  S. De Geest,et al.  Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[7]  S. van der Linden,et al.  The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. , 2003, The Journal of rheumatology.

[8]  V. Conn,et al.  Medication-Taking Beliefs of Adult Renal Transplant Recipients , 2003, Clinical nurse specialist CNS.

[9]  D. Paterson,et al.  Measurement of Adherence to Antiretroviral Medications , 2002, Journal of acquired immune deficiency syndromes.

[10]  David W Bates,et al.  Medication errors observed in 36 health care facilities. , 2002, Archives of internal medicine.

[11]  S. Geest,et al.  Behavioral Strategies for Long‐Term Survival of Transplant Recipients , 2002 .

[12]  M. Skeans,et al.  The natural history of azathioprine compliance after renal transplantation. , 2001, Kidney international.

[13]  J. Cramer,et al.  A systematic review of the associations between dose regimens and medication compliance. , 2001, Clinical therapeutics.

[14]  J. Hackman,et al.  A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. , 2001, The American journal of medicine.

[15]  C. Rand,et al.  Derivation of adherence metrics from electronic dosing records. , 2001, Journal of clinical epidemiology.

[16]  J. Dipiro,et al.  RENAL TRANSPLANT PATIENT COMPLIANCE WITH FREE IMMUNOSUPPRESSIVE MEDICATIONS.: Abstract# 591 , 2000 .

[17]  A. Karch.  2001 Lippincott's Nursing Drug Guide , 2000 .

[18]  H. Corriveau,et al.  Clinical evaluation of patient following stroke: Proposed stroke patient taxonomy based on cluster analysis method , 2000 .

[19]  M. Goormastic,et al.  A tool to identify risk factors for noncompliance in the adult renal transplant recipient. , 1999, Transplantation proceedings.

[20]  S. Nock,et al.  Noncompliance in living-related donor renal transplantation: the United Network of Organ Sharing experience. , 1999, Transplantation proceedings.

[21]  S De Geest,et al.  Methodological issues in transplant compliance research. , 1999, Transplantation proceedings.

[22]  S. Greenstein,et al.  Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. , 1998, Transplantation.

[23]  S. De Geest,et al.  Symptom experience associated with maintenance immunosuppression after heart transplantation: patients' appraisal of side effects. , 1998, Heart & lung : the journal of critical care.

[24]  M. Henry,et al.  Medication compliance following renal transplantation. , 1998, Transplantation.

[25]  D. Shoskes,et al.  Patient death or renal graft loss within 3 yr of transplantation in a county hospital: importance of poor initial graft function. , 1997, Clinical Transplantation.

[26]  B Vrijens,et al.  Comparing compliance patterns between randomized treatments. , 1997, Controlled clinical trials.

[27]  C. Blixen,et al.  Relationship between Pretransplant Noncompliance and Posttransplant Outcomes in Renal Transplant Recipients , 1996, Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization.

[28]  S. Geest,et al.  INCIDENCE, DETERMINANTS, AND CONSEQUENCES OF SUBCLINICAL NONCOMPLIANCE WITH IMMUNOSUPPRESSIVE THERAPY IN RENAL TRANSPLANT RECIPIENTS , 1995, Transplantation.

[29]  N. Zuhdi,et al.  Medication noncompliance and its relationship to financial factors after heart transplantation. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  B. Siegal.  Postrenal transplant compliance: report of 519 responses to a self-report questionnaire. , 1993, Transplantation proceedings.

[31]  R. Pollak,et al.  A STUDY OF TREATMENT COMPLIANCE FOLLOWING KIDNEY TRANSPLANTATION , 1993, Transplantation.

[32]  G Koren,et al.  Compliance assessed by the Medication Event Monitoring System. , 1991, Archives of disease in childhood.

[33]  Alexa Stuifbergen.  Patterns of functioning in families with a chronically ill parent: an exploratory study. , 1990, Research in nursing & health.

[34]  W. Bilker,et al.  Potential utility of electronic drug compliance monitoring in measures of adverse outcomes associated with immunosuppressive agents , 1999, Pharmacoepidemiology and drug safety.

[35]  Urs A. Meyer,et al.  Drug regimen compliance : issues in clinical trials and patient management , 1999 .

[36]  A. Karch.  Lippincott's nursing drug guide , 1997 .

[37]  N. Sumrani,et al.  Causes of late renal allograft failure in the ciclosporin era. , 1992, Nephron.